Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (71-80 of 355) with videos related to

Pageof 36
Sort By:
Methods in Enzymology|January 18, 2020
High-throughput identification of human antigen-specific CD8<sup>+</sup> and CD4<sup>+</sup> T cells using soluble pMHC multimersMorgane Magnin, Philippe Guillaume, George Coukos, et al.
Cancer Research|May 2, 2013
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumorsJaikumar Duraiswamy, Karen M Kaluza, Gordon J Freeman, et al.
Cancer Discovery|August 2, 2024
Lung Cancer Adoptive Cell Therapy: Inspiring TIL ACT Comes Center StageMichael T Lotze, Markus Maeurer, Sergio A Quezada, et al.
The Lancet. Oncology|August 1, 2019
Rational combinations of immunotherapy with radiotherapy in ovarian cancerFernanda G Herrera, Melita Irving, Lana E Kandalaft, et al.
Advances in Experimental Medicine and Biology|December 29, 2006
Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancerGeorge Coukos, Jose R Conejo-Garcia, Ron Buckanovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Endothelin B receptor, a new target in cancer immune therapyLana E Kandalaft, Andrea Facciabene, Ron J Buckanovich, et al.
The Lancet. Oncology|September 5, 2020
Turning up the heat on non-immunoreactive tumours: opportunities for clinical developmentMaría Ochoa de Olza, Blanca Navarro Rodrigo, Stefan Zimmermann, et al.
Biochimica Et Biophysica Acta|August 5, 2015
Personalized approaches to active immunotherapy in cancerEran Ophir, Sara Bobisse, George Coukos, et al.
Journal for Immunotherapy of Cancer|July 14, 2022
Low-dose irradiation for reversing immunotherapy resistance: how to translate?Maria Ochoa-de-Olza, Jean Bourhis, George Coukos, et al.
The Lancet. Oncology|March 31, 2022
Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLCMaria Ochoa-de-Olza, Jean Bourhis, George Coukos, et al.
Pageof 36

Showing results (71-80 of 355) with videos related to

Sort By:
Pageof 36
Methods in Enzymology|January 18, 2020
High-throughput identification of human antigen-specific CD8<sup>+</sup> and CD4<sup>+</sup> T cells using soluble pMHC multimersMorgane Magnin, Philippe Guillaume, George Coukos, et al.
Cancer Research|May 2, 2013
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumorsJaikumar Duraiswamy, Karen M Kaluza, Gordon J Freeman, et al.
Cancer Discovery|August 2, 2024
Lung Cancer Adoptive Cell Therapy: Inspiring TIL ACT Comes Center StageMichael T Lotze, Markus Maeurer, Sergio A Quezada, et al.
The Lancet. Oncology|August 1, 2019
Rational combinations of immunotherapy with radiotherapy in ovarian cancerFernanda G Herrera, Melita Irving, Lana E Kandalaft, et al.
Advances in Experimental Medicine and Biology|December 29, 2006
Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancerGeorge Coukos, Jose R Conejo-Garcia, Ron Buckanovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Endothelin B receptor, a new target in cancer immune therapyLana E Kandalaft, Andrea Facciabene, Ron J Buckanovich, et al.
The Lancet. Oncology|September 5, 2020
Turning up the heat on non-immunoreactive tumours: opportunities for clinical developmentMaría Ochoa de Olza, Blanca Navarro Rodrigo, Stefan Zimmermann, et al.
Biochimica Et Biophysica Acta|August 5, 2015
Personalized approaches to active immunotherapy in cancerEran Ophir, Sara Bobisse, George Coukos, et al.
Journal for Immunotherapy of Cancer|July 14, 2022
Low-dose irradiation for reversing immunotherapy resistance: how to translate?Maria Ochoa-de-Olza, Jean Bourhis, George Coukos, et al.
The Lancet. Oncology|March 31, 2022
Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLCMaria Ochoa-de-Olza, Jean Bourhis, George Coukos, et al.
Pageof 36